Article
Exploring the potential of IL-10 for risk assessment and early intervention in pediatric ALL.
BMC cancer - 8 Aug 2024
Radwan Roqaia E, Darwish Ahmad, Elsaid Afaf M, El-Kholy Wafaa M
Abstract excerpt
Acute lymphoblastic leukemia (ALL), a leading cause of childhood cancer, targets immune system B and T cells. While understanding its causes is crucial, predicting susceptibility holds immense power for early diagnosis and intervention. This study explored the potential of interleukin 10 (IL-10), a key immune regulator, as a predictive tool in Egyptian children. Investigating 100 ALL patients and 100 healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
